Evidence map›Paper›PMID 34993643›Full record

ArticleEuropean journal of nutrition2022

Individual variability in patterns and dynamics of fecal gluten immunogenic peptides excretion after low gluten intake.

Laura Coto, Carolina Sousa, Angel Cebolla

Open access · hybridAbstract read
In one paragraph

Article in European journal of nutrition, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 20 citations in OpenAlex.

  1. Novel probiotic preparation withMicrobiology spectrum · 2024
    Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Laura CotoBiomedal S.L., Polígono Industrial Parque Plata, Calle Calzada Romana, 40, 41900, Camas, Sevilla, Spain.ORCID http://orcid.org/0000-0002-3883-2027
Carolina SousaDepartment of Microbiology and Parasitology, Faculty of Pharmacy, University of Seville, 41012, Seville, Spain.ORCID http://orcid.org/0000-0002-9235-9496
Angel CebollaBiomedal S.L., Polígono Industrial Parque Plata, Calle Calzada Romana, 40, 41900, Camas, Sevilla, Spain. acebolla@biomedal.com.ORCID http://orcid.org/0000-0002-6976-4522
Biomedal (Spain) · ESUniversidad de Granada · ESUniversidad de Sevilla · ES

Funding

Centre for Industrial Technological Development IDI-20180051Consejería de Economía, Innovación, Ciencia y Empleo, Junta de Andalucía AT17_5489_USECorporación Tecnológica de Andalucía 17/957Ministerio de Ciencia, Innovación y Universidades DI-16-08943
6 · The paper itself

Abstract

purposeDetermination of Gluten Immunogenic Peptides (GIP) in feces is a direct tool for gluten exposure detection. The sensitivity of GIP detection methods for cases of unintentional low gluten intakes is unknown. We studied the interindividual variability in the kinetic of excretion under homogeneously controlled dietary conditions, and the sensitivity of fecal GIP tests after low amounts of punctual gluten ingestions.

methodsParticipants (n = 20) followed the same gluten-free menu for 12 days in which two separated doses of gluten (50 mg and 2 g) were ingested and all the depositions were collected. GIP from stool samples were analyzed by ELISA and lateral flow immunoassay (LFIA) tests.

resultsMost participants had detectable GIP after 50 mg and 2 g gluten ingestions using ELISA test (72.2% and 95%, respectively), whereas the LFIA test showed less sensitivity (22.2% and 80%, respectively). GIP were detected at higher either frequency or concentration in the range of 12-36 h after 50 mg intake, and 12-84 h after 2 g consumption. Considering this period, diagnostic sensitivity of GIP detection after a single 50 mg ingestion may be significatively increased analyzing three stool samples per individual. High variability among participants was found in the time and amount of GIP excretion; however, some individuals showed common patterns for both gluten intakes.

conclusionSporadic gluten exposure detection may require several fecal samples to achieve level of sensitivity above 90%. Interindividual variability in the dynamic of GIP excretion may suggest patterns of gluten metabolism.

Indexed as

Celiac DiseaseGlutensDiet, Gluten-FreeEnzyme-Linked Immunosorbent AssayHumansPeptidesGlutensPeptidesCeliac diseaseGluten detection fecesGluten-free diet monitoringGluten immunogenic peptidesGluten metabolism

Identifiers

PMID34993643
PMCPMC8739026
OpenAlexW4205134474

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.